Overview
Emergency study to test the safety of Descartes-30 cells in patients with moderate-to-severe acute respiratory distress syndrome (ARDS) AND COVID-19
Eligibility
Inclusion Criteria:
- Patients must be 18 years of age or older at the time of enrollment
- Patient maintains a diagnosis of moderate or severe ARDS according to the Berlin definition of ARDS
Exclusion Criteria:
- Patient is currently enrolled into another therapeutic clinical trial with an experimental therapy that has not received marketing approval by U.S. FDA.
- Patient is in moribund state with expected survival <24 hours.